Luke Wisniewski
Overview
Explore the profile of Luke Wisniewski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu X, McDowell C, Blaschke C, Liu L, Grimsley G, Wisniewski L, et al.
Anal Chem
. 2023 May;
95(19):7475-7486.
PMID: 37126482
Sialic acid isomers attached in either α2,3 or α2,6 linkage to glycan termini confer distinct chemical, biological, and pathological properties, but they cannot be distinguished by mass differences in traditional...
2.
Wisniewski L, Braak S, Klamer Z, Gao C, Shi C, Allen P, et al.
Front Oncol
. 2023 May;
13:1135405.
PMID: 37124496
Introduction: Outcomes following tumor resection vary dramatically among patients with pancreatic ductal adenocarcinoma (PDAC). A challenge in defining predictive biomarkers is to discern within the complex tumor tissue the specific...
3.
Wisniewski L, Braak S, Klamer Z, Gao C, Shi C, Allen P, et al.
bioRxiv
. 2023 Jan;
PMID: 36711795
Outcomes following tumor resection vary dramatically among patients with pancreatic cancer. A challenge in defining predictive biomarkers is to discern within the complex tumor tissue the specific subpopulations and relationships...
4.
McDowell C, Klamer Z, Hall J, West C, Wisniewski L, Powers T, et al.
Mol Cell Proteomics
. 2021 Feb;
20:100012.
PMID: 33581409
The early detection of pancreatic ductal adenocarcinoma (PDAC) is a complex clinical obstacle yet is key to improving the overall likelihood of patient survival. Current and prospective carbohydrate biomarkers carbohydrate...
5.
Gao C, Wisniewski L, Liu Y, Staal B, Beddows I, Plenker D, et al.
Clin Cancer Res
. 2020 Oct;
27(1):226-236.
PMID: 33093149
Purpose: A subset of pancreatic ductal adenocarcinomas (PDACs) is highly resistant to systemic chemotherapy, but no markers are available in clinical settings to identify this subset. We hypothesized that a...